BioMotiv forms strategic partnership with pharma giant Bristol-Myers Squibb

BioMotiv of Cleveland has added a powerhouse partner to advance its mission of accelerating breakthrough medical discoveries.

The biotech accelerator on Wednesday morning, Sept. 4, announced it has formed a strategic partnership with New York-based pharmaceutical giant Bristol-Myers Squibb Co. (NYSE: BMY) that will “will leverage the strengths of both organizations to develop new and innovative therapies for patients who need them most.”

Click here to read the complete article.

Story excerpt provided by Crain’s Cleveland Business.

Written by Scott Suttell .

Originally published September 4, 2019.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: